Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate (CSC-AA)
This study has been completed.
Sponsor:
Manhattan Eye, Ear & Throat Hospital
Collaborators:
LuEsther T. Mertz Retinal Research Center
Alcon Laboratories
Information provided by (Responsible Party):
Joan, Manhattan Eye, Ear & Throat Hospital
ClinicalTrials.gov Identifier:
NCT00489840
First received: June 20, 2007
Last updated: October 24, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |